摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

二(2,2,2-三氟乙氧基)三苯基膦烷 | 67696-25-7

中文名称
二(2,2,2-三氟乙氧基)三苯基膦烷
中文别名
——
英文名称
bis(2,2,2-trifluoroethoxy)triphenylphosphorane
英文别名
bis(2,2,2-trifluoroethoxy)triphenylphoshorane;DTPP-F6;triphenyl-bis-(2,2,2-trifluoro-ethoxy)-λ5-phosphane;Triphenylbis(2,2,2-trifluoroethoxy)phosphorane;triphenyl-bis(2,2,2-trifluoroethoxy)-λ5-phosphane
二(2,2,2-三氟乙氧基)三苯基膦烷化学式
CAS
67696-25-7
化学式
C22H19F6O2P
mdl
——
分子量
460.356
InChiKey
DJFGMNKBERPKDJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    127-129 °C

计算性质

  • 辛醇/水分配系数(LogP):
    7
  • 重原子数:
    31
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    8

SDS

SDS:4e64d4f9127248a209c4fdab634cca89
查看

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS THAT INHIBIT MCL-1 PROTEIN<br/>[FR] COMPOSÉS INHIBANT LA PROTÉINE MCL-1
    申请人:AMGEN INC
    公开号:WO2017147410A1
    公开(公告)日:2017-08-31
    Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I, and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.
    本文提供了髓样细胞白血病1蛋白(Mcl-1)抑制剂,其制备方法,相关的药物组合物,以及使用这些物质的方法。例如,本文提供了化合物I的公式,及其药用盐和含有这些化合物的药物组合物。本文提供的化合物和组合物可以用于治疗癌症等疾病或症状。
  • BIS(FLUOROALKOXY)TRIPHENYLPHOSPHORANES: PREPARATION AND REACTIONS
    作者:Toshio Kubota、Tomoya Kitazume、Nobuo Ishikawa
    DOI:10.1246/cl.1978.889
    日期:1978.8.5
    Bis(fluoroalkoxy)triphenylphosphoranes were prepared by the replacement of bromines of triphenylphosphine dibromide by fluoroalkoxides [C6H5C(CF3)2ONa, and CF3CH2ONa]. Alcohols and carboxylic acids readily reacted with Ph3P(OCH2CF3)2 to form corresponding 2,2,2-trifluoroethyl ethers and esters, respectively. Ph3P(OC(CF3)2C6H5]2, however, was so stable that it did not undergo reactions with these hydroxyl
    双(氟烷氧基)三苯基膦是通过用氟代醇盐 [C6H5C(CF3)2ONa 和 CF3CH2ONa] 代替二溴化三苯基膦的溴来制备的。醇和羧酸很容易与 Ph3P(OCH2CF3)2 反应,分别形成相应的 2,2,2-三氟乙基醚和酯。然而,Ph3P(OC(CF3)2C6H5]2 非常稳定,不会与这些羟基化合物发生反应。
  • A duality of mechanism in the hydrolysis of acyclic phosphoranes
    作者:Nicholas Lowther、C. Dennis Hall
    DOI:10.1039/c39850001303
    日期:——
    Acyclic phosphoranes, ArnP(OR)5–n with n= 0–3 are shown to hydrolyse in neutral conditions by an SN 1 (P) mechanism for n= 1, 2, and 3 but an SN2 (P) or addition–elimination mechanism for n= 0; this is analogous to the classical SN1 vs. SN2 mechanisms observed reactions at tetrahedral carbon.
    无环膦中,Ar Ñ P(OR)5- ñ与Ñ = 0-3由一个显示出在中性条件下水解小号Ñ 1(P)机构,用于Ñ = 1,2,和3,但一个小号Ñ 2(P )或加法消除机制,n = 0;这类似于在四面体碳上观察到的经典S N 1与S N 2机理。
  • Heterobicyclo intermediates
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04321383A1
    公开(公告)日:1982-03-23
    A compound of the formula ##STR1## wherein R.sub.1 is hydrogen, lower alkyl, phenyl lower alkyl or halo substituted lower alkyl; R.sub.2 is hydrogen, lower alkyl, phenyl lower alkyl or halo substituted lower alkyl; n is 0, 1 or 2; X is --(CH.sub.2).sub.m Z--; Z is oxygen, sulfur or imino; m is 0 or 1; Y is S--R or ##STR2## R is hydrogen, lower alkyl, ##STR3## R.sub.3 is lower alkyl, phenyl or phenyl lower alkyl; and R.sub.4 is hydroxy, amino, hydroxyamino or lower alkoxy. These compounds are useful as hypotensive agents.
    一种化合物的分子式为##STR1##其中R.sub.1是氢、低碳基、苯基低碳基或卤代低碳基;R.sub.2是氢、低碳基、苯基低碳基或卤代低碳基;n为0、1或2;X是--(CH.sub.2).sub.m Z--;Z是氧、硫或亚胺基;m为0或1;Y是S--R或##STR2## R是氢、低碳基、##STR3## R.sub.3是低碳基、苯基或苯基低碳基;R.sub.4是羟基、氨基、羟胺基或低碳氧基。这些化合物可用作降压剂。
  • Carboxyacyl, mercapto and acylmercapto derivatives of heterobicyclo
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04303662A1
    公开(公告)日:1981-12-01
    A compound of the formula ##STR1## wherein R.sub.1 is hydrogen, lower alkyl, phenyl lower alkyl or halo substituted lower alkyl; R.sub.2 is hydrogen, lower alkyl, phenyl lower alkyl or halo substituted lower alkyl; n is 0, 1 or 2; X is--(CH.sub.2).sub.m Z--; Z is oxygen, sulfur or imino; m is 0 or 1; Y is S-R or ##STR2## R is hydrogen, lower alkyl, ##STR3## R.sub.3 is lower alkyl, phenyl or phenyl lower alkyl; and R.sub.4 is hydroxy, amino, hydroxyamino or lower alkoxy. These compounds are useful as hypotensive agents.
    该公式化合物的化学式为##STR1##其中R.sub.1是氢、低碳基、苯基低碳基或卤代低碳基;R.sub.2是氢、低碳基、苯基低碳基或卤代低碳基;n为0、1或2;X是--(CH.sub.2).sub.m Z--; Z是氧、硫或亚胺基;m为0或1;Y是S-R或##STR2##R为氢、低碳基、##STR3##R.sub.3为低碳基、苯基或苯基低碳基;R.sub.4为羟基、氨基、羟氨基或低烷氧基。这些化合物可用作降压剂。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐